Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
Metastatic Bladder Cancer: First Organ Spread
Metastatic Bladder Cancer: First Organ Spread 4

Bladder cancer can spread to other parts of the body. Knowing where it goes first is key for early treatment. This helps improve chances of survival. What is the first organ bladder cancer spreads to? Learn about metastatic bladder cancer and the dangerous, crucial facts on the pattern of disease progression.

The lymph nodes are the primary site for bladder cancer metastasis. Studies show that up to 69% of bladder cancer cases spread to lymph nodes. Lymph nodes are important for our immune system. When cancer gets there, it can change how the disease grows.

Key Takeaways

  • The first organ bladder cancer typically spreads to is the lymph nodes.
  • Lymph node involvement occurs in up to 69% of metastatic bladder cancer cases.
  • Understanding the initial sites of bladder cancer spread is key to effective treatment.
  • The lymph nodes play a big role in the immune system and cancer growth.
  • Early detection of bladder cancer metastasis can improve survival chances.

Understanding Metastatic Bladder Cancer

Metastatic Bladder Cancer: First Organ Spread
Metastatic Bladder Cancer: First Organ Spread 5

Metastatic bladder cancer is a complex condition. It needs a deep understanding of its types, stages, and how it spreads. Knowing the basics is key to understanding its progression and its impact on patients.

Types and Stages of Bladder Cancer

Bladder cancer is mainly classified into several types. The most common is urothelial carcinoma, or transitional cell carcinoma, making up about 90% of cases. Other types include squamous cell carcinoma and adenocarcinoma. Knowing the type is important for choosing the right treatment.

The staging of bladder cancer uses the TNM system. It looks at the tumor’s size and spread (T), lymph node involvement (N), and distant metastasis (M). Stages range from:

  • Stage I: Cancer is in the bladder’s inner layer.
  • Stage II: Cancer has grown into the muscle layer of the bladder.
  • Stage III: Cancer has spread beyond the muscle layer to nearby tissues or lymph nodes.
  • Stage IV: Cancer has spread to distant lymph nodes or other organs, showing metastatic bladder cancer.

How Cancer Cells Spread Beyond the Bladder

Cancer cells can break away from the bladder tumor. They spread through the bloodstream or lymphatic system. Common places for metastasis include lymph nodes, bones, lungs, and liver.

Understanding how bladder cancer spreads is key to effective treatments. The speed of metastasis varies. It depends on the cancer’s genetics, the patient’s health, and the success of initial treatments.

Metastatic Bladder Cancer: First Organ Spread
Metastatic Bladder Cancer: First Organ Spread 6

Exploring metastatic bladder cancer’s complexities is ongoing. A deep understanding of its types, stages, and spread is vital for better patient care. Staying updated with research and treatments helps improve management and care for those with this disease.

Lymph Nodes: The Primary Site of Bladder Cancer Metastasis

Lymph nodes play a key role in bladder cancer treatment. They are small, bean-shaped structures in the body’s lymphatic system. This system fights infection and disease. In bladder cancer, lymph nodes are the main place for cancer to spread, affecting treatment and outcomes.

Why Lymph Nodes Are Affected in up to 69% of Cases

Lymph nodes are often the first place bladder cancer spreads. Cancer cells can travel through the lymphatic system to these nodes. Studies show that up to 69% of bladder cancer cases involve lymph nodes, showing their importance in the disease’s spread.

The lymphatic system’s role in metastasis is complex. It transports cancer cells to lymph nodes, where they can grow. This can cause lymph nodes to swell, a sign of cancer spread.

Pelvic and Regional Lymph Node Involvement

The pelvic and regional lymph nodes are the first defense against bladder cancer spread. These nodes are in the pelvis and nearby areas. Their involvement is key in determining the cancer’s stage and prognosis.

Regional lymph node involvement is important because it shows a more advanced cancer. The number and location of involved nodes help in staging and treatment planning.

Impact of Lymph Node Metastasis on Treatment Decisions

Lymph node metastasis greatly affects bladder cancer treatment. The presence and extent of involvement can determine whether surgery, chemotherapy, radiation, or a mix of treatments is necessary. For localized disease, surgery to remove the bladder and affected nodes might be chosen. In advanced cases, systemic therapies like chemotherapy or immunotherapy are often used.

Treatment planning involves a team of healthcare professionals. Urologists, medical oncologists, and radiation oncologists work together. They create a personalized treatment plan based on lymph node involvement and other factors.

Bone: The Second Most Common Site of Spread

Bone metastasis is a big worry in bladder cancer, happening in about 47% of patients. When bladder cancer reaches the bone, it can cause many problems. These issues can make life harder and affect treatment results.

Patterns of Bone Metastasis in Bladder Cancer

Bone metastases from bladder cancer usually hit the spine, pelvis, and ribs. These are often osteolytic, meaning they break down the bone. The way it spreads can change symptoms and how it’s treated.

Symptoms and Complications of Bone Metastases

Patients with bone metastases from bladder cancer might feel pain, have fractures, or face spinal cord issues. These problems can really hurt their quality of life. They need quick and good care.

The pain from bone metastases can be very bad. It might need more than one kind of painkiller to manage. Fractures happen when the bone gets weak from the cancer. Spinal cord issues can cause nerve problems.

Treatment Approaches for Bone Involvement

Handling bone metastases in bladder cancer needs a team effort. This includes medicines, radiation, and support. The goal is to control the cancer and ease symptoms.

Radiation therapy helps with pain and stops fractures or spinal cord issues. Bisphosphonates and other drugs can also help prevent bone problems.

Lung Metastasis and Other Distant Organs

Bladder cancer spreading to distant organs, like the lungs, is a big worry. We need to know where bladder cancer can go beyond its first spot.

Lung Involvement in Bladder Cancer

About 37% of bladder cancer cases spread to the lungs. This can cause breathing problems and other issues. Early detection is key to handling lung metastasis well.

Liver, Brain, and Other Less Common Sites

Bladder cancer can also go to the liver and brain, but it’s not as common. The liver might get affected, causing liver problems. Brain metastasis, though rare, is tough to treat. Knowing these patterns helps in making a detailed treatment plan.

Detecting Distant Metastases Through Imaging

Imaging is key in finding distant metastases. We use CT scans, MRI, and PET scans to spot cancer in places like the lungs, liver, and brain. Getting an accurate diagnosis through imaging is vital. It helps us see how far the cancer has spread and plan the best treatment.

Timeline and Risk Factors for Metastatic Bladder Cancer

Knowing how fast bladder cancer spreads is key for both patients and doctors. Metastatic bladder cancer means the disease has spread to other parts of the body. The speed of spread depends on the cancer type and stage.

Speed of Bladder Cancer Spread

The speed of bladder cancer spreading varies by type. For example, small cell carcinoma spreads faster than others. It can take months to years for cancer to spread from the bladder to other areas. Early detection is important because bladder cancer often has no symptoms in its early stages.

Several factors affect how fast cancer spreads. These include the cancer’s grade and stage at diagnosis and the patient’s health. Tumors that are more abnormal and aggressive are more likely to spread. Knowing these factors helps doctors create better treatment plans.

High-Risk Features That Increase Metastatic Potentia

Some features increase the chance of bladder cancer spreading. These include:

  • High-grade tumors: These tumors are more abnormal and aggressive.
  • Muscle-invasive bladder cancer: This indicates a more advanced stage of cancer.
  • Lymphovascular invasion: Cancer cells in blood vessels or lymphatic channels help cancer spread.
  • Certain genetic mutations: Some genetic changes make cancer more aggressive.

Spotting these risk factors early can help manage the disease better.

Survival Statistics Based on Metastatic Sites

Survival rates for metastatic bladder cancer depend on where the cancer spreads. For example, patients with cancer in lymph nodes have a better outlook than those with cancer in distant organs like the liver or bones. The five-year survival rate for stage 4 bladder cancer is about 5-15%.

Knowing these survival rates helps patients and doctors make better treatment choices.

Treatment Options for Patients with Metastatic Bladder Cancer

The treatment for metastatic bladder cancer has changed, giving patients new hope. It’s important to know the different treatment options available.

Systemic Therapies: Chemotherapy and Immunotherapy

Systemic therapies are key in treating metastatic bladder cancer. Chemotherapy is often used, with treatments like gemcitabine and cisplatin. But immunotherapy has brought new hope, with drugs like pembrolizumab and atezolizumab improving survival chances.

“Immunotherapy has changed how we treat metastatic bladder cancer,” says an oncologist. “It offers a more effective and easier-to-take option for patients.”

Site-Specific Treatments for Different Metastatic Locations

Site-specific treatments are also important for managing metastatic bladder cancer. For example, bisphosphonates or denosumab can help those with bone metastases. Radiation therapy can also help patients with specific metastatic sites, improving their quality of life.

Multidisciplinary Approach to Metastatic Disease Management

Managing metastatic bladder cancer requires a team effort. Doctors, surgeons, and other healthcare professionals work together. This ensures each patient gets a treatment plan that fits their needs.

Dr. [Last Name] says, “A team approach means patients get all-around care. We address the cancer and its symptoms and side effects.”

In summary, treating metastatic bladder cancer needs a detailed and personalized plan. This includes systemic therapies, site-specific treatments, and a team of experts. By using these methods, we can help patients get the best care and support during their cancer journey.

Conclusion: Advances in Understanding and Treating Metastatic Bladder Cancer

Our knowledge of metastatic bladder cancer has grown a lot. This has led to better ways to treat it. We’ve learned how it spreads to different parts of the body and how this affects treatment plans.

New treatments for bladder cancer are helping patients more. Chemotherapy and immunotherapy are showing great results. Places like Liv Hospital are leading the way in giving top-notch care to those with metastatic bladder cancer.

We’re getting better at treating metastatic bladder cancer. By focusing on specific areas and working together, we can make treatments more effective. This progress shows how vital research and teamwork are in fighting cancer.

FAQ


What are the common types of bladder cancer that can metastasize?

Bladder cancer can spread in several ways. The main types are urothelial carcinoma, squamous cell carcinoma, and adenocarcinoma. Urothelial carcinoma is the most common, making up about 90% of cases.

Where does bladder cancer typically spread to first?

First, bladder cancer usually goes to the lymph nodes. These nodes are key to our immune system and often get cancer first.

What is the role of lymph nodes in bladder cancer metastasis?

Lymph nodes are very important in the spread of bladder cancer. They get cancer in up to 69% of cases. Cancer in these nodes can change treatment plans and affect how long you might live.

How does bladder cancer spread to bones?

Bladder cancer can reach the bones through the blood or lymph. About 47% of cases spread to the bones. This can cause pain, fractures, and high calcium levels.

What are the symptoms of lung metastasis from bladder cancer?

Lung metastasis can cause cough, shortness of breath, and chest pain. Sometimes, there are no symptoms, and tests are needed to find it.

Can bladder cancer spread to other organs besides lymph nodes, bones, and lungs?

Yes, bladder cancer can go to other places like the liver, brain, and more. How often it goes to these places varies. Tests help find and track it.

How quickly does bladder cancer spread?

Bladder cancer spreads at different rates. It depends on the cancer type, stage, and the person. Some grow fast, while others grow more slowly.

What are the treatment options for metastatic bladder cancer?

Treatments for metastatic bladder cancer include chemotherapy and immunotherapy. There are also treatments for specific places where cancer spreads. A team of doctors usually works together to treat it.

How does the site of metastasis affect survival statistics?

Where cancer spreads affects survival chances. For example, cancer in lymph nodes is often better than in distant organs. This can change how long someone might live.

What is metastatic urothelial carcinoma?

Metastatic urothelial carcinoma is when urothelial cancer spreads to distant places or lymph nodes. It’s a type of bladder cancer that needs treatment that targets the whole body.

References

Park, W. K., Kim, Y. S., & Ilsan Hospital Department of Urology (2012). Pattern of lymph node metastasis correlates with tumor location in bladder cancer. Investigative and Clinical Urology, 53(1), 14-17.https://doi.org/10.4111/kju.2012.53.1.14

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
GDPR

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
Trusted Worldwide
30
Years of
Experience
30 Years Badge
Health Türkiye Accreditation

Trusted Worldwide

30 Years of Experience

Patient Reviews
Reviews from 9,651
4,9
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 42 04